ストックスクリーナーアプリを入手
16.81
2.55%
-0.44
アフターアワーズ：
17.00
0.19
+1.13%
前日終値:
$17.25
開ける：
$17.11
24時間の取引高:
1.32M
Relative Volume:
0.43
時価総額：
$1.05B
収益：
$16.10M
当期純損益:
$-198.97M
株価収益率:
-4.8292
EPS:
-3.4809
ネットキャッシュフロー:
$-183.99M
1週間 パフォーマンス:
+3.13%
1か月 パフォーマンス:
+5.46%
6か月 パフォーマンス:
-71.98%
1年 パフォーマンス:
+79.02%
1日の値動き範囲:
$16.21
$17.17
1週間の範囲:
$13.21
$18.20
52週間の値動き範囲:
$8.73
$71.50
Uniqure N V Stock (QURE) Company Profile
Compare QURE vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QURE
Uniqure N V
|
16.81 | 1.08B | 16.10M | -198.97M | -183.99M | -3.4809 |
VRTX
Vertex Pharmaceuticals Inc
|
435.65 | 112.35B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
746.00 | 79.71B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
828.35 | 52.29B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.13 | 44.48B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
320.70 | 35.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-11 | アップグレード | Mizuho | Neutral → Outperform |
| 2026-03-09 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2026-03-09 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2026-03-03 | ダウングレード | Mizuho | Outperform → Neutral |
| 2026-03-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2026-03-02 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2026-03-02 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-24 | 開始されました | Wolfe Research | Peer Perform |
| 2026-01-28 | 開始されました | Barclays | Equal Weight |
| 2025-11-04 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-08-14 | アップグレード | Mizuho | Neutral → Outperform |
| 2025-04-01 | 再開されました | Chardan Capital Markets | Buy |
| 2024-12-10 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-02-29 | ダウングレード | Goldman | Buy → Neutral |
| 2023-12-19 | ダウングレード | Mizuho | Buy → Neutral |
| 2022-03-17 | アップグレード | UBS | Neutral → Buy |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-05-21 | 開始されました | UBS | Neutral |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-04-01 | アップグレード | Mizuho | Neutral → Buy |
| 2021-01-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-11-24 | 開始されました | H.C. Wainwright | Buy |
| 2020-11-11 | 開始されました | Berenberg | Buy |
| 2020-11-09 | 開始されました | Jefferies | Buy |
| 2020-11-04 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-10-23 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-08-25 | 開始されました | Raymond James | Strong Buy |
| 2020-07-31 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | ダウングレード | Mizuho | Buy → Neutral |
| 2020-06-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | 開始されました | Cowen | Outperform |
| 2019-12-03 | 開始されました | Goldman | Buy |
| 2019-11-05 | 開始されました | Credit Suisse | Outperform |
| 2019-10-11 | 開始されました | Stifel | Buy |
| 2019-09-25 | 開始されました | Bernstein | Outperform |
| 2019-09-12 | 開始されました | Mizuho | Buy |
| 2019-07-30 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-07-08 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2019-04-12 | 開始されました | Piper Jaffray | Overweight |
| 2019-03-29 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Uniqure N V (QURE) 最新ニュース
(QURE) Risk Channels and Responsive Allocation - Stock Traders Daily
UniQure shares surge 26% on US FDA shakeup even as momentum tumbles: Will new leadership greenlight Huntington's therapy? - MSN
UniQure NV (NASDAQ:QURE) Q4 2025 earnings call transcript - MSN
uniQure (NASDAQ:QURE) Trading Down 3.7%Here's What Happened - MarketBeat
Early UniQure Fabry trial shows lasting enzyme boost, safety watch - MSN
UniQure used 'distorted comparison' in Huntington's asset trial: FDA official - MSN
uniQure (NASDAQ:QURE) Trading Up 10.9%Still a Buy? - MarketBeat
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure N.V. Lawsuit – QURE - GlobeNewswire
QURE CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - Rutland Herald
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire Inc.
QURE UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - PR Newswire
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
uniQure N.V. 24 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against uniQure N.V.QURE - ACCESS Newswire
QURE DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds uniQure N.V. Investors to Join the Class Action Lawsuit Today - ACCESS Newswire
QURE Deadline: QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit - lincolnjournal.com
uniQure's Approval Process Hits a Roadblock—Savvy Investors Are Pulling Out Ahead of Further Declines - Bitget
Uniqure NV at TD Cowen Healthcare Conference Transcript - GuruFocus
Q4 2025 Uniqure NV Earnings Call Transcript - GuruFocus
uniQure Investors Face Deadline in Class Action Lawsuit - National Today
Barclays reaffirms equal weight rating for uniQure (QURE) - MSN
uniQure N.V. 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against uniQure N.V.QURE - Business Wire
QURE Deadline: Rosen Law Firm Urges uniQure N.V. (NASDAQ: QURE) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Bluefield Daily Telegraph
UNIQURE DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders ... - Bluefield Daily Telegraph
UNIQURE DEADLINE MONDAY: Bragar Eagel & Squire, P.C. - GlobeNewswire
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - ACCESS Newswire
Energy Moves: Will uniQure NV benefit from geopolitical trendsWeekly Trading Summary & Safe Entry Point Alerts - baoquankhu1.vn
uniQure N.V. (NASDAQ: QURE) Investor Alert: Deadline in Lawsuit on April 13, 2026 - openPR.com
QURE FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages uniQure N.V. Investors with Losses ... - Caledonian Record
QURE 4-DAY DEADLINE ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data - ChartMill
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V.QURE - ChartMill
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming DeadlinesQURE - PR Newswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
INVESTOR DEADLINE: uniQure (QURE) Investors with - GlobeNewswire
William Blair Downgrades uniQure N.V. (QURE) - MSN
QURE ALERT: Hagens Berman Updates uniQure (QURE) Probe After FDA Criticism, Lawsuit Filed; April 13 Deadline Nears - The Malaysian Reserve
QURE Stockholders Have Opportunity to Lead uniQure N.V. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
uniQure N.V. Securities Fraud Class Action Result of FDA - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE - ChartMill
QURE ALERT: Hagens Berman Updates uniQure (QURE) Probe After FDA - GuruFocus
FDA Criticizes uniQure's Gene Therapy, Lawsuit Filed - National Today
QURE Shareholder Alert: uniQure N.V. Securities Class Action Law - GuruFocus
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of Upcoming Deadline - TMX Newsfile
QURE Shareholders Have Opportunity to Lead uniQure N.V. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
QURE Shareholder Alert: uniQure N.V. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm - PR Newswire
Press releases provided by CNW - Techaeris
UniQure surges following departure of key FDA official - MSN
Investors in uniQure N.V. Should Contact Levi & Korsinsky Before April 13, 2026 to Discuss Your Rights – QURE - GlobeNewswire
uniQure N.V. Faces Class Action Lawsuit Deadline - National Today
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
UNIQURE N.V. (NASDAQ: QURE) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises ... - Caledonian Record
QURE Investors Have Opportunity to Lead uniQure N.V. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Uniqure N V (QURE) 財務データ
収益
当期純利益
現金流量
EPS
Uniqure N V (QURE) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Abi-Saab Walid | Chief Medical Officer |
Mar 04 '26 |
Sale |
9.06 |
808 |
7,320 |
189,669 |
| Potts Jeannette | Chief Legal Officer |
Mar 04 '26 |
Sale |
9.06 |
3,412 |
30,913 |
138,483 |
| KLEMT CHRISTIAN | Chief Financial Officer |
Mar 04 '26 |
Sale |
9.06 |
12,000 |
108,720 |
226,581 |
0.45%
0.77%
大文字化:
|
ボリューム (24 時間):